Ligand Pharmaceuticals
LGND
#4138
Rank
S$2.96 B
Marketcap
$156.95
Share price
4.47%
Change (1 day)
100.62%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.08

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.11. In 2022 the company made an earnings per share (EPS) of -$2.67 a decrease over its 2021 EPS that were of $4.66.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.08-177.91%
2022-$2.67-157.23%
2021$4.66-2571.43%
2020-$0.19-100.46%
2019$41.22353.48%
2018$9.091025%
2017$0.81-700%
2016-$0.13-100.87%
2015$15.571859.32%
2014$0.795.36%
2013$0.758.0704505322479E+18%
2012$0.0000000000-100%
2011$0.66-194.23%
2010-$0.70548.38%
2009-$0.11-98.7%
2008-$8.32-136.52%
2007$22.78-787.8%
2006-$3.31-14.58%
2005-$3.88-21.31%
2004-$4.93-55.15%
2003-$10.9981.33%
2002-$6.062.74%
2001-$5.90-45.93%
2000-$10.91-14.56%
1999-$12.77-45.52%
1998-$23.43-3.97%
1997-$24.40132.31%
1996-$10.50

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.05 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.71 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.45 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.50 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.31 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.35 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.89 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.97 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA